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Abstract 
Infectious animal diseases caused by pathogenic microorganisms such as bacteria and viruses threaten the health 
and well‑being of wildlife, livestock, and human populations, limit productivity and increase significantly economic 
losses to each sector. The pathogen detection is an important step for the diagnostics, successful treatment of animal 
infection diseases and control management in farms and field conditions. Current techniques employed to diagnose 
pathogens in livestock and poultry include classical plate‑based methods and conventional biochemical methods as 
enzyme‑linked immunosorbent assays (ELISA). These methods are time‑consuming and frequently incapable to dis‑
tinguish between low and highly pathogenic strains. Molecular techniques such as polymerase chain reaction (PCR) 
and real time PCR (RT‑PCR) have also been proposed to be used to diagnose and identify relevant infectious disease 
in animals. However these DNA‑based methodologies need isolated genetic materials and sophisticated instruments, 
being not suitable for in field analysis. Consequently, there is strong interest for developing new swift point‑of‑care 
biosensing systems for early detection of animal diseases with high sensitivity and specificity. In this review, we pro‑
vide an overview of the innovative biosensing systems that can be applied for livestock pathogen detection. Different 
sensing strategies based on DNA receptors, glycan, aptamers and antibodies are presented. Besides devices still at 
development level some are validated according to standards of the World Organization for Animal Health and are 
commercially available. Especially, paper‑based platforms proposed as an affordable, rapid and easy to perform sens‑
ing systems for implementation in field condition are included in this review.
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1 Introduction
Infectious diseases are the leading causes of death of 
humans and animals worldwide. Wildlife and domestic 
animals pathogen infections threat animal production 
and food supply, seriously impact animal welfare and 
have potential environmental and global biodiversity 
consequences. There is a clear economic cost of animal 
infectious disease as they impact large‑scale develop‑
mental projects. In addition, viral infections of animal 
population carry global public health risks of sporadic 
human zoonotic infections or emergence of a pandemic 
viral strain. Animals are thought to be the source of more 
than 70% of all emerging infections [1].
One of essential elements for implementation of an 
efficient response to infectious disease threats is a rapid, 
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selective and sensitive assay for pathogen diagnostics. 
Current research attempts to adopt a multidisciplinary 
approach for both identification of underlying patho‑
genic agents and control infectious diseases spread. 
Certainly, early detection of pathogen is crucial for man‑
aging infections and establishing improved decision‑
making tools.
Conventional methods for viral detection include virus 
or microorganism propagation and isolation from cul‑
ture. These methods are effective and sensitive but tend 
to be costly, labor intensive and time consuming (typically 
results are available in 2–10  days). Alternative molecu‑
lar methods based on polymerase chain reaction (PCR), 
real time PCR (RT‑PCR) are more specific, sensitive and 
take less time, but they need isolated genetic materials, 
manipulation with special care and necessitate sophisti‑
cated equipment, and, thus, they are hardly to be applied 
for on‑site monitoring. Consequently, development of a 
valid diagnostic assay for swift pathogen detection and 
identification, with high sensitivity and selectivity is a 
challenge for researchers all over the world.
Biosensors, as analytical devices, are attractive solu‑
tions for fast and efficient infectious disease diagnos‑
tics due to their simplicity, possible miniaturization and 
potential ability for real‑time analysis [2–6]. Over the 
past 30 years, a number of biotechnological innovations 
have provided biosensors for bacterial and viral detection 
and monitoring. Some emerging systems have resulted 
in promising prototypes that achieved rapid patho‑
gen detection without demanding high level of sample 
manipulation which is highly inconvenient for infected 
samples.
In this review we will focus on biosensors that can be 
applied for domestic animal pathogen diagnostics. Differ‑
ent biomarkers of animal infectious diseases (as proteins, 
DNA, RNA) and commonly used in biosensing tech‑
nologies, especially for virus detection are considered in 
details. Examples are given for pathogens responsible for 
major economic losses in cattle, pig, sheep and poultry 
farming.
2  Principal of biosensing technology
Biosensor recognizes a target biomarker, characteris‑
tic for particular pathogen, via an immobilized sens‑
ing element called bioreceptor (monoclonal antibody, 
RNA, DNA, glycan, lectin, enzyme, tissue, whole cell). 
The bioreceptor is a crucial component as its biochemi‑
cal properties assure high sensitivity and selectivity of 
the biomarker detection and permit to avoid interfer‑
ences from other microorganisms or molecules present 
in the tested sample. The specific biochemical interaction 
between the biomarker and the bioreceptor is converted 
into a measurable signal by the transductor (Figure  1). 
Signal recording and display should, then, allow qualita‑
tive and quantitative pathogen identification.
There are two principal challenges to develop a biosen‑
sor for pathogen detection: (i) elaboration of a bioassay 
for biomarker detection, and (ii) improving the robust‑
ness of the bioassay to adapt it for applications in field 
and/or on complex biological samples. Indeed, many 
bioassays that work well on the bench with purified bio‑
marker molecules fail to detect them in complex media 
like blood or serum. In addition, diagnostics of infection 
disease require high sensitivity since pathogens might 
spread rapidly before that any clinical sign appears in 
animals.
3  Detection of Escherichia coli
Escherichia coli (E. coli) is a Gram‑negative rod‑shaped 
bacterium, diversified into harmless strains, normally 
found in the lower intestine microbiota of humans 
and animals, and virulent strains that cause infections, 
including gastroenteritis, urinary tract infection, men‑
ingitis, peritonitis, and septicemia. In poultry, E. coli 
causes colibacillosis characterized by the migration of 
the virulent strains, as O78:K80, O1:K1, and O2:K1, from 
intestine to other organs as respiratory or urinary tracts. 
These infections decreases egg production, reduce 
chicken grow, increase mortality and cause important 
economic losses. For instance, in 2011, an outbreak of a 
highly virulent E. coli in Europe resulted in subsequent 
food withdrawals from the market and export bans lead‑
ing to about $417 million negative economic impact 
for EU farmers [7]. Colibacillosis is also seen in a vari‑
ety of farm animals like cattle, pigs, goats [8] and has a 
significant economic importance concerning the loss 
of livestock. In cattle, pathogenic variants of E. coli are 
responsible for diseases, as septicemia and diarrhea in 
newborn calves or acute mastitis in dairy cows. The use 
of antibiotic in colibacillosis treatment and prevention 
is become an even greater problem than the infection 
Figure 1 Principle of biosensors. A schematic diagram of patho‑
gen detection by a biosensor.
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itself. The extensive antibiotic use in animal production 
has incidence on the spread of multidrug‑resistant bac‑
teria and on antibiotic‑resistant infections in humans. In 
most developed countries, serious consideration is being 
undertaken to regulate and severely restrict the use of 
antibiotics in animal production. The rapid and accurate 
diagnostic of virulent E. coli strains is vital for assessing 
the antibiotic resistance information, for administration 
of appropriate treatment and thus for avoiding useless 
antibiotics utilization.
The main issue in E. coli diagnostic is to distin‑
guish between the closely related strains in order to 
distinguish between pathogenic and non‑pathogenic 
species. Commonly used methods for E. coli detec‑
tion and identification include culture, fermentation, 
enzyme linked immunosorbent and PCR assay. These 
methods show disadvantages in terms of long identi‑
fication time (typically few days), high labor and rea‑
gent cost [9, 10]. Novel biosensors based on specific 
biochemical recognition strategies have been reported 
for rapid and specific E. coli detection as those based 
on PCR [11], quartz crystal microbalance system [12], 
surface plasmon resonance [13], chemiluminescence 
[14] and electrochemistry [15–17]. The biosensors for 
E. coli diagnostics are elaborated to assure two major 
steps: the capture of target bacteria from the biological 
or environmental samples and subsequent identifica‑
tion of captured bacterial sub‑type. A huge variety of 
high affinity antibodies against E. coli that bind to sur‑
face/flagella proteins is available, as well as appropri‑
ate labels that can be employed for the amplification of 
detectable signal (as enzymes, biofunctionalized nano‑
particles or fluorophores). These allow development of 
various sandwich‑type immunosensors and immuno‑
assays for rapid detection of E. coli in infected samples.
Immunosensor developed by Jaffrezic‑Renault et  al. 
[18] is based on the following strategy: addressable 
magnetic nanoparticles coupled with anti‑LPS anti‑
bodies were used for the generic capture of Gram‑
negative bacteria onto the graphite ink electrode. The 
use of immunomagnetic beads allow detection of a 
biomarker contained in complex sample matrices. 
Conductometric measurements allowed real‑time, 
sensitive detection of E. coli or Serratia marcescens 
cultures from 1 to 103  CFU/mL. The conductometric 
immunosensor permitted also the direct detection of 
10 to 103  CFU/mL of Pseudomonas aeruginosa and 
Acinetobacter baumannii strains that were undetect‑
able using standard immunoblot methods. Gram‑pos‑
itive bacteria such as Staphylococcus epidermidis were 
not detected indicating the specificity of detection 
[19].
Eltzov and Marks [20, 21] have proposed a point‑of‑
care detection system based on stacked paper mem‑
branes that quantify E. coli within less than 5  min. 
When liquid samples containing bacteria are added 
onto the bottom membrane layer, the liquid starts to 
migrate from the lower to the upper layers. As each 
layer becomes wet, E. coli cells from contaminated 
samples push through to the next membrane layers. 
During migration, the bacterial cells bind with the spe‑
cific antibody, itself conjugated with horseradish per‑
oxidase (HRP) enzyme to allow signal measurement. 
In target‑free samples, the HRP‑labeled anti‑E. coli 
antibodies from migrating are stopped by previously 
immobilized target bacteria on the capture layer. The 
upper‑most layer contains the HRP enzymatic sub‑
strate producing a measurable signal only with sam‑
ples containing target E. coli. This portable and rapid 
immunoassay was shown to have around 1000‑folds 
higher sensitivity than ELISA since only 100  cells/mL 
were successfully quantified.
4  Detection of avian influenza viruses
Aquatic birds constitute the main reservoir for avian 
influenza viruses (AIVs) [22]. These viruses represent a 
global threat to animal health and international poultry 
industry. Particularly high concern represents pandemic 
emergences which may cause enormous economic losses. 
AIVs are divided into low and highly pathogenic strains 
regarding their pathogenicity for chicken. The highly 
pathogenic AIV (HPAIV) spreads rapidly in domestic 
poultry and result in high mortality rate. The low path‑
ogenic AIV (LPAIV) may cause mild respiratory or gas‑
trointestinal symptoms, but usually without any signs of 
illness. However, LPAIV strains may acquire high patho‑
genicity during multiple infections in a chicken popula‑
tion [23].
Based on their antigenic specificity, Influenza A 
viruses infecting birds, are divided into 16 hemagglu‑
tinins (HA, H1‑16) and 9 neuraminidases (NA, N1‑9) 
subtypes. To date, naturally occurred HPAIV that pro‑
duce high mortality in chickens, turkeys and other 
birds of economic importance have been restricted 
only to H5, H7 and H9 subtypes. Of these viruses, some 
H5N1, H7N2 and H7N7 viruses have shown to cause up 
to 100% mortality with 48 h in infected chickens. Many 
outbreaks of HPAIV occurred in domestic poultry 
production systems as it was the case with the highly 
pathogenic avian influenza H5N8 virus since 2014 
[24]. H5N1 viruses have affected the poultry indus‑
try in numerous countries for the past 15  years and 
have resulted in the deaths of millions of birds. Con‑
sequently, a global influenza virological surveillance 
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in poultry populations and migratory birds is recom‑
mended by both by World Organization for Animal 
Health (OIE) and World Health Organization (WHO) 
[25, 26]. Availability of a swift and sensitive AIV diag‑
nosis tool that allows virus strain identification will be 
highly useful for disease surveillance as well as for opti‑
mizing biosecurity measures on farms.
Avian influenza virus belong to the Influenza A virus 
family Orthomyxoviridae. The genome of AIV is consti‑
tuted by eight segments of negative‑stranded RNA. Ten 
main proteins are encoded by viral genome: the poly‑
merase basic protein 1 (PB1) and 2 (PB2), hemagglutinin 
(HA), nucleoprotein (NP), neuraminidase (NA), the poly‑
merase acidic protein (PA), matrix proteins 1 and 2, and 
non‑structural protein 1 and 2 [27]. Some other influenza 
A virus proteins were found as PB1‑F2, PB1‑N40, PA‑X, 
NEP, M42, PA‑N155, PA‑N182 [28–31]. Potentially all 
these viral proteins, as well as their corresponding cod‑
ing RNA sequences, are AIV biomarkers. Nevertheless, 
frequent mutations in the AIV genome lead to changes in 
antigenic properties which restrained the choice of bio‑
markers. HA, M2 and NA are the dominant targets for 
the host antibody response, anti‑viral drug development 
and represent also the targets in diagnostics assays.
A broad of traditional serological diagnostic methods 
like haemagglutination (HA) test, Hemagglutination‑
inhibition (HI) test, neutralization (NT) and ELISA test 
are available as well as those based on virus propagation 
and isolation from cell culture or embryonated chicken 
eggs. These methods are effective and sensitive but they 
require relatively important amount of virus particles and 
special sample collection and handling tend to be costly, 
labor intensive and time‑consuming. Moreover, HPAIV, 
as H5N1, are quite virulent for eggs, killing them quickly. 
This makes standard egg culture amplification procedure 
quite difficult. Alternative molecular methods based on 
PCR and RT‑PCR are more sensitive but need extracted 
genetic material and require the use of equipment which 
is available only in diagnostic or scientific laboratories. 
In consequence, on‑site detection of avian influenza 
viruses is rare until now for both early diagnostics and 
monitoring [32–34]. Similarly, a variety of different sero‑
logical tests that detect the response of the infected host 
are established but they are not adapted to strains which 
have a pandemic potential. Moreover they are not robust 
and are difficult to be employed in point‑of‑care condi‑
tion [35]. There are several bedside tests which allow a 
relatively quick (up to 30 min) detection of viral antigens 
[36]. Unfortunately, these tests provide low sensitivity 
and often produce false negative results, especially dur‑
ing later stages of the disease development. Low sensitiv‑
ity is the main reason why these tests are rarely used in 
routine diagnostics of influenza virus.
Influenza hemagglutinin (HA) surface protein binds to 
sialic acid glycan residues (α‑2,6 and α‑2,3 sialic acids) 
on the surface of human and bird cells. HAs expressed 
by AIV bind specifically to the α‑2,3 sialic acid which is 
preferentially expressed in the intestine of water‑flow, 
while HA proteins from human‑adapted viruses prefer to 
bind to the α‑2,6 sialic acid glycan, mainly expressed on 
the epithelial cells of the human upper respiratory tract. 
Based on this difference in sialic acid linkages, biosensors 
were developed for detecting and differentiating between 
avian and human influenza viruses. Glycan‑immobilized 
field effect transistor biosensor was shown to detect and 
discriminate between human (H1) and avian (H5) influ‑
enza viruses at attomolar‑level sensitivity [37]. Surface 
plasmon resonance [38, 39], optical waveguides [40] and 
quartz crystal microbalance [41] were also employed in 
glycan‑based AIV detection. HA binding to sialic acid 
attached to gold nanoparticles allows detection of influ‑
enza virus in solution without any pretreatment or ampli‑
fication step [42]. This reaction may produce a signal in 
colorimetric test that is linearly proportional to the virus 
titer (Figure 2). A recent study reported that glycan can 
be printed onto glass slides to generate microarray [43]. 
The microarray was shown to capture different strains of 
influenza virus with a clinical relevant limit of detection 
(ten plaque forming units) allowing virus diagnostics.
Most of portable antibody‑based methods for influenza 
virus diagnosis, including those being commercialized, 
are lateral flow tests [44]. Lateral flow tests may detect a 
specific influenza biomarker in a complex media thanks 
to their chromatography component consisting of series 
of pads that transport samples spontaneously during the 
test (Figure 3).
Samples to be detected for influenza virus by lateral 
flow test are solubilized in a detergent containing solu‑
tion and deposited on the sample pad. This step initi‑
ates lateral flow of sample components. In the first step 
of detection a specific influenza virus biomarker is rec‑
ognized by antibodies carried by gold‑nanoparticles 
pre‑adsorbed on the conjugate pad. Usually antibodies 
raised against preserved epitopes in viral nucleoprotein 
are used for this step. Influenza viruses complexed with 
immune‑gold nanoparticles reach the test lines. Two 
test lines with pre‑immobilized antibodies that specifi‑
cally recognize either influenza A or B virus bind to dif‑
ferent epitopes of the virus and, in that way accumulate 
immune‑gold nanoparticles carrying the viruses. The 
accumulation of gold nanoparticles results in an appear‑
ance of a visible red line. Usually, antibodies recognizing 
specific epitopes in HA proteins are used for the test line. 
Finally, non‑bound immune‑gold nanoparticles arrive at 
the control line which harbors the secondary antibody, 
showing the second visible red line. In the absence of 
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Figure 2 Colorimetric sensor for detection of influenza A virus. Sialic‑mediated colorimetric detection of Influenza virus. Gold nanoparticles 
are stabilized with sialic to specifically bind HA protein on Influenza virus surface. Sialic‑acid gold nanoparticles alone show the absorbance at 
510 nm, while virus‑bound nanoparticles absorbed at 600–610 nm. This allows label‑free colorimetric readout for virus detection. Cartoon adapted 
from [42].
Figure 3 Lateral flow strips for detection of influenza A and B viruses. Schematic presentations of a lateral flow tests realized on a nitrocellu‑
lose strips with immobilized antibodies against influenza virus A and B. A sample containing influenza virus flow by capillarity from the sample pad 
to bind test and control lines. In contrast, a sample without target virus flows from the sample application pad and binds only to the control line.
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viral particles in the sample, the immune‑gold nanopar‑
ticles flow alone and bind only to the control line. Thus, 
two colored lines stand for positive result while a single 
colored line corresponds to negative result (Figure 3). In 
most cases antibodies can distinguish between influenza 
A and B viruses but still not able to differentiate within 
subtypes and, thus, between LPAIV and HPAIV stains. 
In contrast, aptamers generated against specific AIVs or 
specific RNA/DNA primers immobilized on the test lines 
allow AIV sub‑typing.
The extreme simplicity to use, efficiency, reliability 
and label‑free detection characterized lateral flow tests. 
However, their sensitivity is sufficient for detecting pro‑
teins but has to be improved to allow detection of viral 
particles in a complex medium as fecal swab sample. It 
was shown that silver nanoparticles added to the test 
line can amplify the colorimetric signal up to 1000‑fold 
[45]. A limit of detection 0.09 ng/mL was estimated for 
AIV detection by lateral flow test amplified with quan‑
tum dots [46]. For comparison, this test showed 100‑
fold higher sensitivity than ELISA performed with the 
same antibodies. Recently, a quantum‑dot based lat‑
eral‑flow immunoassay system was proposed for quan‑
titative detection of influenza A virus subtypes H5 and 
H9 [47]. The modification of specific antibodies with 
quantum‑dot amplified signal and permitted a quanti‑
tative read‑out of the virus detection under an ultravio‑
let lamp.
Several commercial PCR, RT‑qPCR, RT‑RPA kits 
and portable machines, in a mobile diagnostic suit‑
case, are available on the market for AIV detection and 
subtyping. Some of them combine lateral flow test after 
specific labeled primer‑set amplification to increase the 
sensitivity of lateral flow system. It will be interesting to 
have efficient integrations of available and stable ampli‑
fication and detection assays, for instance, the combi‑
nation of PCR/isothermal amplification and biosensor 
technology. For instance, a portable and rapid assay 
for the detection of the emerging avian influenza A 
(H7N9) virus has been developed in a form of diagnos‑
tics suitcase. The test is based on reverse transcription 
recombinase polymerase amplification (RT‑RPA) assay, 
isothermal amplification and a fluorescence detection 
machine. The workflow consisted of viral nucleic acid 
extraction, isothermal target nucleic acid fragment 
amplification and fluorescence detection [48]. Portable 
nucleic acid thermocyclers including PCR and isother‑
mal amplification has become applicable for rapid on‑
site viral nucleic acid detection despite of the need of 
genetic materials isolation procedure. The combination 
of nucleic acid extraction, amplification and detection 
methods can be varied for different viral strain detec‑
tion (Figure  4). RPA assays for AIV detection can be 
combined with lateral flow test. This combination pro‑
vides a qualitative but not quantitative result (Figure 5).
Recently, an electrochemical immunosensor based on a 
specific anti‑M1 antibody was shown to detect all sero‑
types of influenza A virus [49] with sensitivity similar to 
classical molecular methods (80–100  ×  103  PFU/mL). 
A lower effective limit of 1 × 103 PFU/mL was achieved 
by coupling the anti‑M1 monoclonal antibody to gold 
nanoparticles in a quartz crystal microbalance assay 
Figure 4 Detection of influenza virus RNA. Available combinations of portable nucleic acid extraction, amplification and detection methods for 
virus detection.
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[50]. A sensitive plasmon‑assisted fluoro‑immunoassay 
was developed for the detection of the influenza virus by 
specific anti‑M1 antibodies conjugated to gold nanopar‑
ticle‑decorated carbon nanotubes. After influenza virus 
binding to these mixed nanoparticles, a fluorescent signal 
was produced by addition of cadmium telluride quantum 
dots. A photoluminescence intensity of quantum dots 
was shown to vary as a function of virus concentration, 
with a detection limit of 50 PFU/mL. In another study, it 
was demonstrated that an electrochemical immunosen‑
sor provides a very sensitive platform for detection and 
quantification of PB1‑F2 protein of Influenza A virus in 
infected cells [51, 52]. The detection limit of the device 
was determined as 0.42  nM PB1‑F2 [51]. A PCR‑free 
paired surface plasma wave biosensor has been success‑
fully developed for detection of 2009 pandemic influenza 
A virus [53]. The proposed diagnostic method is rapid, 
sensitive and accurate but only applicable for laboratory 
diagnostics.
Artificial nucleic acids with defined 3D‑structure, 
called aptamers that allow discrimination between differ‑
ent serotypes of influenza viruses are generated using sys‑
tematic evolution of ligands by exponential enrichment 
(SELEX) technology (Figure  6). Aptamers are a good 
alternative to antibodies, because their production is 
not expensive and time‑consuming and does not require 
animal hosts. Aptamers can present binding affinities in 
the picomolar range, thus much higher sensitivities than 
most antibodies can reached. Various aptamers gener‑
ated against AIV proteins have been developed [54, 55]. 
These aptamers showed relatively strict specificity for the 
influenza virus with broad subtype specificities such as 
H5N1 and H1N1. For instance, Wang et al. [55] and Fu 
et al. [54] characterized aptamers that specifically bind to 
H5N1 but not to other AIV subtypes. Aptamers gener‑
ated against avian influenza viruses attached to quantum 
dots allowed both detection of viral particles and their 
labeling for ultrastructural characterization of infected 
samples [56]. Interestingly, some aptamers bind to HA 
protein site that recognize sialic acids at the surface of a 
host cells. Consequently, they can attenuate virus infec‑
tivity which suggests their potential applications as anti‑
viral agents [57, 58].
Many groups develop multiplex detection of different 
influenza subtypes on a single device. Microarrays for 
diagnostic applications are elaborated either for monitor‑
ing pathogen virulence genes or for simultaneous screen‑
ing of multiple pathogens. The majority of influenza 
Figure 5 Lateral flow kits for detection of influenza viruses. RT‑RPA with lateral flow Influenza virus detection kits for influenza A, influenza B, 
Influenza H5 and H7 subtypes. Pictures provided from Hawk Scientific Co., Ltd and GenProNex Biomedical INC. (Flu A: influenza A, Flu B: influenza B).
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microarray utilizes a panel of primers for multiplex PCR 
amplification of the HA, NA and M1 genes of influenza 
viruses. Li et al. [59] coupled a DNA microarray and mul‑
tiplex reverse transcriptase PCR microarrays to provide 
subtyping of influenza virus strains. Similarly, Kessler 
et  al. [60] developed a three‑dimensional DNA flow‑
through biochip for typing and subtyping of influenza 
viruses. Wang et  al. [61] designed a microarray‑based 
detection and genotyping of a wide range of respira‑
tory viruses. In one another study, Townsend et  al. [62] 
described a microarray, for the relatively rapid identifica‑
tion of influenza A virus subtypes H1N1, H3N2 viruses 
circulating in the human population as well as the highly 
pathogenic avian A/H5N1 virus that was isolated from 
poultry in Southeast Asia and that spread to Europe. This 
test demanded extraction and amplification of the viral 
RNA, and thus cannot easily be used on‑site. However, 
the device provided the absolutely correct types and sub‑
types for an average of 72% of the isolates. The authors 
emphasized that the failures were due to the nucleic 
acid amplification step rather than limitations in the 
microarray.
Although microarrays are typically used a fluores‑
cent read‑out there is a great potential of electrochemi‑
cal microarrays for detection of influenza viruses. For 
instance, the microarray silicon chip for the detection of 
influenza A virus based on more than 12 500 electrodes, 
each carrying specific oligomers allowed the genotyping 
and identification of HA and NA influenza A proteins 
and virus subtyping [63]. Current developments are 
focused on miniaturization and automatization of micro‑
array biosensors for building portable diagnostics plat‑
forms for avian influenza viruses.
5  Detection of Mycoplasma and other bovine 
mastitis pathogens
Mycoplasmas are the smallest bacterial cells that lack a 
cell wall around their cell membrane, which makes them 
insensible to many common antibiotics. Antibiotics 
help preventing some clinical signs but cannot eliminate 
infection. Various mycoplasmae strains infect animals, 
but usually play a secondary role in infections by exac‑
erbating pre‑existing disease. Nevertheless, Mycoplasma 
bovis (M. bovis) can play a primary role of pneumonia, 
mastitis or arthritis in cattle. M. bovis is considered as 
one of the most pathogenic and the most frequent Myco-
plasma species. It is estimated that M. bovis infection 
causes €144 million in the European cattle industry [64]. 
Methods used for diagnosis of Mycoplasma infection 
include bacterial culture, fluorescent antibody‑based test, 
serological tests and PCR. Serological tests cannot be 
applied for early diagnosis or for detection of acute infec‑
tion since serum antibody biomarkers rise at 10–14 days 
after acute infection. The somatic cell count as a refer‑
ence method for monitoring milk quality allows mastitis 
diagnosis. This simple but labor‑intensive assay implies 
methods as microscopic analysis or cytometry for raw 
milk. Both methods are slow and require well‑trained 
Figure 6 Aptamer-based detection of influenza viruses. Schematic representations of aptamer development and virus detection. Selex 
procedure is applied for selection of specific aptamers. These sensing elements are immobilized on the sensor surface to bind efficiently to the viral 
proteins in infected samples. The recognition signal is proceeded to provide diagnostic.
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staff to provide result accuracy and reproducibility. Early 
diagnosis is however of the extreme importance due to 
the high costs of treatments. Some portable somatic cell 
counters have been validated and are used as cow‑side 
test for mastitis control at a dairy farm. Although they are 
very simple to apply, they have low sensitivity and speci‑
ficity and usually cannot identify the pathogen strain [65, 
66]. Especially, the early diagnosis of bovine mastitis is 
important regarding its huge impact on farm economics 
due to treatment cost and reduction in milk production.
Biosensors have been developed to detect specific 
Mycoplasma biomarkers in a rapid and easy‑to‑use diag‑
nosis manner. Majority of in‑field biosensors are devel‑
oped to detect NAGase and haptoglobin biomarkers 
in milk samples. Expression of both bacterial proteins 
is characteristic for the acute phase inflammation. For 
instance, oxido/reduction process of 1‑naphthol, which is 
a substrate of NAGase can be easily detected and quanti‑
fied using carbon electrodes. Pamberton et al. [67] have 
reported an electrochemical sensor based on a screen‑
printed carbon electrode which detected NAGase pro‑
tein in milk samples with a limit of detection of 10 mU/
mL. Surface plasmon resonance was employed to moni‑
tor binding of haemoglobin to haptoglobin immobilized 
on the surface of the chip [68]. The formation of this pro‑
tein complex resulted in changes in mass attached to the 
chip surface which indicates mastitis. Though, when this 
biomarker is targeted to test milk samples false positive 
results are obtained in some milk samples that contained 
blood traces.
A single‑stranded DNA aptamer showing high affinity 
and specificity against P48 protein of M. bovis has been 
used in a competitive enzyme‑linked aptamer assay for 
the detection of M. bovis in sera [69]. P48 protein is an 
optimal biomarker for M. bovis since it is an invariable 
protein that is localized on the membrane surface of M. 
bovis. A competitive enzyme‑linked aptamer assay using 
the biotin‑labeled aptamer of P48 protein was applied in 
an indirect diagnostic test. The sensitivity and selectivity 
of the test were similar to commercial ELISA kits.
Mastitis as an inflammatory infection may be caused 
not only by Mycoplasma, but by many other bacteria. The 
most frequent clinical infections in dairy cattle are caused 
by about ten different bacterial pathogens as Staphylococ-
cus aureus, Streptococcus agalactiae, S. bovis, S. canis, E. 
coli. Consequently for controlling the disease spread and 
for targeting antimicrobial therapy a rapid strain identi‑
fication and quantification of the microbial load in milk 
samples is needed. Nowadays, PCR or RT‑ PCR‑based 
tests are employed for laboratory testing. As mentioned 
above, these methods are rapid and sensitive but their 
application for milk samples is sometimes impeded as 
milk contains calcium ions and proteinases that act as 
PCR inhibitors. Various procedures are established for 
DNA extraction and purification from the raw milk. Rea‑
gents for these additional steps are included in commer‑
cial kits which additionally increase reaction time and 
the price per analysis. Nevertheless some PCR‑based kits 
allow identification of total bacterial strains causing mas‑
titis and detection of their antibiotic resistant gens [70].
Advances in the development of the nucleic acid micro‑
array have permitted automatization of the protocols and 
development of multiplex biochips for detection of vari‑
ous dairy pathogens [71]. For instance, a biochip based 
on DNA amplification of genes characteristic for mastitis 
causing pathogens was shown to efficiently detect six other 
pathogens in addition to M. bovis in bovine milk with a 
limit of detection of 103  CFU/mL [72]. More recently a 
test that combined a rapid PCR with a nucleic acid micro‑
array immunoassay was proposed [73]. This colorimetric 
test allowed simultaneous detection and identification of 
six strains from four different mastitis causing pathogens 
within less than 3 h. In the microarray a set of specific anti‑
bodies that recognize tags attached to specific PCR frag‑
ments were immobilized by printing onto nitrocellulose 
membrane. After PCR with tagged primers, the double‑
tagged amplicons were captured between the antibodies 
printed onto the nitrocellulose and carbon nanoparticles 
carrying alkaline–phosphatase. In the presence of the alka‑
line–phosphatase substrate, the black spots appear on the 
membrane that can be easily seen by the naked eye (Fig‑
ure 7). The selectivity of the test was obtained by attach‑
ing different tags to primers specific for each pathogen of 
interest. This experimental approach may be integrated 
into a self‑contained, simple and disposable cassette for 
point‑of‑care multi‑pathogen molecular diagnostics.
An electrochemical sensor based on electrochemical 
impedance spectroscopy was developed for detection of 
pathogenic Staphylococcus aureus ATCC25923 bacteria 
by Braiek et  al. [74]. A linear relationship between the 
increment in the electron transfer resistance and the log‑
arithmic value of S. aureus concentration was observed 
between 10 and 106 CFU/mL. The limit of detection was 
low as 10  CFU/mL, and the reproducibility was calcu‑
lated to 8%. In addition, a good selectivity versus E.  coli 
and S. epidermidis was demonstrated.
6  Detection of Clostridium perfringens
Clostridium perfringens (C. perfringens) is a gram‑posi‑
tive, anaerobic, fermentative, spore‑forming soil bacte‑
rium that may produce one or several exotoxins. At least 
17 different C. perfringens toxins have been identified 
[75, 76], some of them being very potent causing ani‑
mal and food‑borne illnesses, and are even considered 
to be bioweapons. C. perfringens are classified into five 
isotypes (A, B, C, D and E) regarding five major toxins 
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they produce [alpha, iota, alpha, beta (1 and 2), epsilon 
toxins, and enterotoxin E] [77]. In addition, novel toxins 
have been identified, as NetB, which was isolated from 
chickens with necrotic enteritis [78]. The toxin produc‑
tions in animal gut are associated with specific entero‑
toxemias characterized by a variety of symptoms and 
traumatic infections. C. perfringens strains may infect 
birds, dogs, horses, pigs, lambs, cattle, sheep, goats and 
other domestic animals. Although C. perfringens is an 
important enteric pathogen for almost all domestic ani‑
mals, the most advance studies on its pathogenicity have 
been made for broiler chicken. For instance, alpha‑ and 
beta‑toxin of C. perfringens are responsible for clostrid‑
ial enteric disease in poultry. This necrotic enteritis 
cause significant economic losses to the global poultry 
industry due to high mortality rates. Furthermore, some 
strains of C. perfringens that produce enterotoxins at 
sporulation are responsible for foodborne disease in 
humans.
The isolation of C. perfringens alone is not sufficient 
for diagnosis but has to be confirmed with histological 
evaluation of lesions. The lesions in the lamina propria 
associate with a strong inflammation is characteristic for 
early stages of infection, while in later stages, necrosis of 
mucosa and association of gram‑positive rods with the 
lesions is characteristics [79]. The infections are usually 
treated by antibiotics. In farms that stopped using antibi‑
otic growth promoters, outbreaks of clostridial infections 
increase dramatically. In consequence, the improving 
diagnostics and surveillance of C. perfringens are crucial.
Diagnosis of enteric diseases produced by C. perfrin-
gens is usually difficult since these bacteria can nor‑
mally colonize bird gut. Moreover, it was shown that 
alpha‑toxin of C. perfringens is not an essential viru‑
lence factor in the pathogenesis of necrotic enteritis in 
chickens. Thus, the main challenge is to determine the 
biological activity of C. perfringens  in terms of rapid 
strain identification and differentiation of pathogenic 
from non‑pathogenic strains. A solution can be found 
in cell‑based detection systems which are emerging bio‑
sensor technologies that detect the biological activity of 
pathogens or toxins. Those biosensors have mammalian 
cells as sensing elements and allow monitoring pertur‑
bations in cell physiological activities following expo‑
sure [80]. Cell‑based biosensors are capable of detecting 
the presence of pathogens or active toxin in clinical, 
environmental and food samples [2] rendering accurate 
estimation of the risk associated with the agent identi‑
fication. Different device designs are proposed from a 
96‑well plate to modified electrodes carrying mamma‑
lian cells [80].
Each isotype of C. perfringens carries a defined sub‑
set of virulence genes coding for toxin‑producing 
sequences. Sergeev et  al. [81] immobilized specific oli‑
goprobes onto a multipathogen oligonucleotide micro‑
array to detect six toxin‑producing sequences in C. 
Figure 7 Microarray for detection of bacterial nucleic acids. Schematic representation of microarray for mastitis bacteria detection realized 
on porous nitrocellulose membrane slides. Illustration adapted from Mujawar et al. [73].
Page 11 of 22Vidic et al. Vet Res  (2017) 48:11 
perfringens. Sequences encoding the different toxins 
hybridized strongly and specifically to the correspond‑
ing oligoprobes. The microarray‑based test was applied 
on fluorescently‑labeled amplicons obtain by initial 
PCR amplification step [81–83]. After hybridization, 
the microarray was scanned to measure the presence or 
absence of signal above background as an indicator of 
bacterial presence in the tested sample. This experimen‑
tal approach was used for simultaneous analysis for sev‑
eral bacterial stains, their toxin genes or drug resistance 
determinants on a single‑chip platform [84].
Finally, toxins produced by C. perfringens may be 
detected using specific antibodies integrated onto an 
immunosensor. Such a device was demonstrated for sen‑
sitive and label‑free detection of epsilon toxin produced 
by C. perfringens [85]. The sensor was obtained using an 
epsilon‑toxin specific monoclonal antibody immobilized 
onto single walled carbon nanotubes. By controlling the 
morphology of the carbon nanotube assembly the sensor 
was adapted for detection of analytically relevant concen‑
trations of toxin (nM range) and with sensitivities com‑
parable to those of ELISA.
7  Detection of bluetongue and epizootic 
hemorrhagic disease viruses
Bluetongue a major non‑contagious infectious disease of 
domestic and wild ruminants (mainly sheep, cattle, deer) 
is caused by the bluetongue virus which is an orbivirus 
of the Reoviridae family. Bluetongue virus is transmit‑
ted by the bite of a female of certain species of midges 
of the insect family Ceratopogonidae but can also infect 
embryos via the placenta or be transmitted via seminal 
fluid and colostrum [86]. World Organisation for Ani‑
mal Health (Office International des Epizooties, OIE) 
listed bluetongue virus because of its economic impact. 
The worldwide losses, estimated to 3 billion US$ a year 
[87], mainly affect ovine and bovine rearing industries. 
The estimated cost of bluetongue outbreaks in Scotland 
is £100 million per year (£30 million in direct losses and 
£70 million in indirect losses [88]), while the US losses in 
trade and associated testing of cattle for bluetongue virus 
status has been estimated at $130 million a year [89]. It 
is worth noting that although the mortality and morbid‑
ity of bluetongue in cattle are rare; cattle can be infected 
by the virus without showing any clinical sign and in that 
way acting as reservoirs and contributing to the virus 
transmission. In consequence, economic losses come not 
only from direct damages caused by death, or reduced 
meat and milk production, but also from indirect effects 
due to the restriction in animal, semen or serum export‑
ing. The clinical manifestations of bluetongue disease 
range from an unapparent or mild disease, to pyrexia, 
tachypnea, lethargy and even fatal disease [90].
In contrast to bluetongue virus which mainly affects 
sheep, strains of epizootic hemorrhagic disease virus, 
another distinct species within the genus Orbivirus, may 
exhibit high mortality and morbidity in both sheep and 
cows. As both diseases have similar clinical symptoms, 
both can be transmitted by the same insect and both 
have significant negative impacts on trade, the diagnosis 
of Orbiviruses is important. Current methods for blue‑
tongue and epizootic hemorrhagic disease virus include 
numerous nucleic acid amplification assays, genotyp‑
ing viral isolates, DNA microarray and next‑generation 
sequencing [91]. Promising advanced methods, such as 
fluorescent microsphere assays that can be adapted to 
single‑tube multiplexing or multiple‑well multiplexing, 
allow simultaneous detection of various viral RNA by 
in‑solution hybridization [92]. These tests are currently 
under validation in some laboratories. However, other 
alternative amplification methods, as loop‑mediated iso‑
thermal amplification which can allow pen‑site testing, 
or lateral flow test have still not be applied for Orbivirus 
detection. Nevertheless, a rapid lateral flow test for the 
detection of bluetongue virus‑specific antibodies has 
been commercialized and recently validated [93].
Danielli et al. [94] reported a rapid detection of Iba‑
raki virus causing epizootic hemorrhagic disease at 
picomolar concentrations by magnetic modulation and 
synchronous detection. This assay based on fluores‑
cent‑labeled oligonucleotide detection in a homogene‑
ous solution can be integrated into the portable device 
and use for in field rapid virus diagnosis. The cDNA 
of the nonstructural NS3 protein expressed by the 
Ibraki virus served as a biomarker. The complementary 
nucleic acid probe was labeled with three different tags: 
a fluorescent dye and biotin were attached as a double‑
tag at the 5′ end, while a dark quencher was attached at 
the 3′ end (Figure 8). Following a PCR cycle, the probe 
was attached to the streptavidin‑coated magnetic bead 
via the biotin tag. It was shown that each magnetic bead 
may attach thousands of labeled probed, which allowed 
to concentrate probes into the detecting area. Sample 
concentration and separation can be easily performed 
by external magnetic field. In this assay, during PCR, 
the fluorescent energy transfer (FRET)‑based probe 
hybridized with its complementary sequence (Figure 8). 
Then, FRET‑based probe is cleaved by Taq‑polymerase 
which allows the fluorescent light to be produced. The 
intensity of the fluorescent light can be calibrated to the 
pathogen concentration, and used as measure of viral 
titer in infected samples. In comparison, authors shown 
that their system distinguish target from control probe 
after a single cycle of PCR while classical RT‑PCR gave 
significant signal only after 12 cycles, while laser scan‑
ning microscopy required 18 amplification steps to give 
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signal above the threshold level. This promising bio‑
sensor was shown to detect 1.9  pM of the virus NS3 
cDNA within 18  min, without needing any separation 
or washing step.
8  Detection of Eimeria species
Intracellular protozoan parasite Eimeria causes coccidi‑
osis which represents an important health problem in 
the poultry industry worldwide. The economic losses 
of the poultry industry due to coccidiosis are estimated 
to US$7 billion a year, mostly due to the late diagnosis 
because symptoms are not visible at the initial stages of 
infection. Eimeria undergoes rapidly its life cycle inside 
cells in intestinal tract of the infected bird. Upon finish‑
ing the internal phase in which the parasite is multiplied 
and excreted as oocysts in the faeces, it undergoes sporu‑
lation in the external phase and becomes infective. Infec‑
tion in chicken leads to low feed conversion rate, reduced 
weight gain and increased mortality. At least seven dif‑
ferent Eimeria species can affect poultry showing no 
cross‑immunity between them [95]. Usually under field 
conditions, coccidiosis is caused by infection with mixed 
but one dominant Eimeria specie. The damage occurring 
in the intestinal tract may facilitate secondary infection 
by some nonrelated bacteria, as documented for C. per-
fringens [96], or Salmonella Typhimurium [97, 98].
Traditional diagnosis employed in surveillance and 
control of coccidiosis is based on correlation of parasite 
size, morphology and site of infection with histological 
observation of lesions in infected birds. In addition to be 
complex and time consuming, these methods may also 
confuse coccidiosis with histomoniasis and salmonellosis 
due to their similar lesions. Biochemical and molecular 
diagnostic tools involve DNA based high‑throughput 
analysis which permits to distinguish between distinct 
genetic parasites [99]. New multiplex PCR assays, using 
primer pairs characteristic for all seven Eimeria causing 
infections in poultry, are performed on oocysts purified 
from the feces [100]. Application of PCR‑based assay for 
the presence of Eimeria oocysts on farms indicated limi‑
tations because of the assay low sensitivity (a minimum 
detection level was found to be 20 oocysts). This points 
out that classical PCR analysis cannot be applied for early 
infection diagnosis [101]. Advances PRC technologies 
provide methods more adapted for early diagnosis as ran‑
dom amplification of polymorphic DNA PCR, DNA fin‑
gerprinting protocols and qPCR [102–104].
An alternative to classical PCR is a loop‑mediated iso‑
thermal amplification (LAMP) method reported for the 
first time by Notomi et  al. [105]. LAMP is highly sen‑
sitive, specific and simple nucleic acid amplification 
method that functions at single constant temperature. 
It is also a time‑saving method since an entire ampli‑
fication is reached within less than 60  min. Overall, 
LAMP is quite adapted for elaboration of pathogens 
point‑of‑care diagnostic kits. LAMP is allowed by auto‑
cycling strand‑displacement reaction using a set of oli‑
gonucleotides specific for different DNA sequences 
within the target genomic region and formation of a 
loop‑structured amplicon. To improve amplification, 
additional loop primers may be added to the reaction. 
Barkway et al. [106, 107] have developed a panel of sen‑
sitive LAMP‑based assays for diagnosis of seven Eimeria 
species that infect chickens. The test validation was per‑
formed on DNA extracted from mechanically disrupted 
Eimeria oocysts purified from faecal material. This study 
Figure 8 Fluorescent detection of viral nucleic acids on mag-
netic beads. Schematic presentation of the FRET‑based magnetic 
biosensor for Orbiviruses detection. (1) A nucleic acid probe labeled 
with florescent dye, biotin and dark quencher hybridize with the 
complementary probe, (2) the fluorescent dye is separate from the 
quencher in each PCR cycle, and starts to produce light, (3) the fluo‑
rescent dye bind to streptavidin‑coated magnetic beads via biotin 
tag, (4) about 1000 fluorescent‑labeled probes bind to a single beads 
giving an increased fluorescent signal. Cartoon adapted from [94].
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suggested that, although non‑quantitative, LAMP‑based 
diagnostics of coccidiosis parasite show many advan‑
tages: (i) the colorimetric read‑out provided an instant 
result as no requirement for electrophoresis step; (ii) 
test sensitivity allowed parasite detection upon ongoing 
infection, and at early stages when any visible lesions can 
be resolved; (iii) LAMP was less sensitive to PCR inhibi‑
tors present in tested samples as some metal‑ions or pro‑
teases compared to PCR and, finally, (iv) the completed 
test was cheaper than ~£1 per sample. Thus, simplicity, 
low cost and no requirement for sophisticated laboratory 
equipment make the LAMP‑colorimetric paper test a 
good candidate for in field applications.
9  Detection of foot-and-mouth disease viruses
Foot‑and‑mouth disease virus causes an extremely infec‑
tious and contagious disease of cloven‑hoofed animals 
as cattle, pigs, sheep and many wild species. Although 
showing a low mortality, foot‑and‑mouth disease has the 
global impact estimated between US$6.5 and 21 billion a 
year, due to high morbidity of the disease and the huge 
numbers of animals affected [108]. It was estimated that 
one infected cow can infect more than 70 cattle, which 
makes foot‑and‑mouth virus the most infectious human 
and animal pathogen known. The clinical symptoms of 
food‑and‑mouth disease are formation of painful fluid‑
filled vesicles (blisters) or some erosion on the mouth tis‑
sues as tongue and lips, or other parts of the body where 
the skin is thin, like between the two toes of the feet. The 
pain causes many supplementary symptoms as depres‑
sion, excessive salivation, lameness, anorexia and reluc‑
tance to move or stand.
The developed countries have eradicated the foot‑
and‑mouth disease but widespread and long distance 
movements of animals sometimes re‑incur virus. The 
outbreaks in disease free regions cause economic losses 
of about US$1.5 billion a year. Therefore a rapid imple‑
mentation of the measures and a coordination between 
regions and countries are needed to control disease 
spread [109]. However, even nowadays the virus iden‑
tification cannot be done in all endemic regions. Many 
developing countries during the suspected outbreaks 
have to send infected samples to international laborato‑
ries because of the lack of resource and laboratory equip‑
ment. The transportation represents a major biosecurity 
risk, increases time of analysis and risk of sample degra‑
dation and has additional cost. In consequence, there is 
a need for a portable device for in field foot‑and‑mouth 
diagnosis to assure better disease control, surveillance 
and management in outbreaks.
The food‑and‑mouth virus belongs to the Aphthovirus 
genus of the Picornaviridae family. It consists of a single‑
stained positively‑charged RNA genome surrounded by 
a capsid composed of four structural peptides VP1‑4. 
There are seven immunologically and genetically distinct 
serotypes. There is no cross protection between different 
serotypes which implies that an outbreak diagnostic of 
both virus and of their serotype have to be done. Classi‑
cal methods for the food‑and‑mouth diagnostics involve 
virus isolation, ELISA and RT‑PCR tests [109]. Recently 
an improved duplex one‑step RT‑PCR assays was vali‑
dated [110]. The main advantage of this test is in the 
co‑amplification of foot‑and‑mouth virus RNA and host 
β‑actin mRNA. Host mRNA served as an intern control 
to ensure accuracy and to avoid false negative results that 
occur when quality of RNA in samples is poor. Although 
the assay was validated as specific and sensitive, it is only 
adapted to laboratory diagnostics.
Fowler et  al. [111] reported a lateral flow device for 
recovery of food‑to‑mouth viral RNA. In their assay 
the virus detection and subtype identification were per‑
formed in laboratory facilities while the lateral flow 
device was only proposed to improve field sample pres‑
ervation during transport. To test the proof of concept, 
the authors applied epithelial suspension or cell culture 
infected with a food‑to‑mouth virus representing various 
serotypes on the antigen lateral flow strip. Specific anti‑
gen–antibody reaction resulted in development of the 
test line. This lateral flow device was then employed as a 
dry, thermos‑stable and non‑hazardous transport system 
of infected sample for subsequent nucleic acid amplifica‑
tion, sequencing or virus recovery in laboratory facilities.
Reid et al. [112] developed a rapid and simple chroma‑
tographic strip foot‑and‑mouth diagnostic test for field 
application. This device was shown to detect specifically 
foot‑and‑mouth disease virus antigen in laboratory and 
field condition. The chromatographic strip test contained 
a specific monoclonal antibody with broad reactivity for 
foot‑and‑mouth disease viruses. The device was vali‑
dated with laboratory‑based tests on a range of samples 
as nasal swabs, epithelial suspensions and probangs from 
clinical samples or from animals infected experimentally 
as well as in supernatant fluids resulting from their pas‑
sage in cell culture.
Another example of a preliminary validated point‑
of‑care test for foot‑and‑month disease diagnosis is a 
device that coupled reverse transcription loop‑mediated 
isothermal amplification (RT‑LAMP) with a lateral flow 
strips [113]. The test provided diagnosis within less than 
1 h with no requirement for instrumentation because the 
test line is visible by a naked eye. Moreover, the test can 
be performed in a standard water bath or heating block 
because RT‑LAMP technique does not require a ther‑
mocycler as it amplifies specific nucleotide sequences 
at a constant temperature. The validation of the device 
has shown a successful detection of foot‑and‑month 
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disease virus RNA from epithelial suspensions without 
the need for prior RNA extraction. All these advantages 
together with a possibility that a RT‑LAMP method can 
be adapted for a high throughput system make this assay 
attractive for field use.
10  Detection of Campylobacter
Campylobacter is a Gram‑negative spiral‑shaped bac‑
terium, mobile with flagella, which belongs to the 
Campylobacteriaceae family. It is microaerophilic and 
thermophilic microorganism that can grow well at the 
temperature range between 37 and 42  °C. Campylobac-
ter can cause diseases in humans and animals including 
wild animals, pets and livestock species. C. jejuni, C. coli 
and C. fetus strains have been found worldwide. Particu‑
larly, C. jejuni and C. coli have been found in sheep, cat‑
tle, chickens, turkeys, dogs, cats and pigs while C. fetus 
has been found mostly in sheep, goats and cattle. C. 
jejuni, mostly found in poultry, may colonize the intes‑
tine of turkeys, chickens and waterfowl. Clinical signs of 
infection are enteritis with diarrhea, vomiting and fever, 
but also abortions and infertility, bovine genital campy‑
lobacteriosis, ileitis in hamsters, colitis in ferrets, enteri‑
tis in porcine. Lesions of infected young animals include 
edema of the mucosa of the ileum and cecum, mononu‑
clear infiltration of the submucosa, villous atrophy with 
intraluminal accumulation of mucus. In addition, animals 
can be infected asymptomatically with any of Campylo-
bacter strains. For instance, C. jejuni is not considered to 
be pathogenic in birds. Still, some cases of C. jejuni infec‑
tion in chickens have been reported to cause enteritis and 
death.
Poultry is considered as the main source of human 
campylobacteriosis [114, 115], the disease caused by 
the infection with Campylobacter. The WHO recom‑
mended a control and surveillance of Campylobacter in 
poultry to reduce the risk for humans since this bacte‑
rium has a significant impact on public health. In fact, 
contaminated, undercooked poultry is responsible for 
50–80% of cases of campylobacteriosis investigated. Nev‑
ertheless, contaminated beef and pork products are also 
responsible for some infections of people. Costs due to C. 
jejuni infections are estimated between US$1.5 billion to 
US$8.0 billion a year and about €2.4 billion a year, in the 
United States and Europe, respectively [116, 117].
The recommended procedure for detection of Campy-
lobacter requires 4 days to provide response on its pres‑
ence or absence, while up to 7 more days are required 
for Campylobacter strain identification. Microaerophilic 
conditions, a specific temperature, and selective enrich‑
ment media are required to grow Campylobacter in lab‑
oratory. However, classical plate based methods are not 
quite suitable for diagnostics Campylobacter. First, the 
strain differentiation between C. jejuni and C. coli is diffi‑
cult using conventional cellular or biochemical methods, 
because of the similar characteristics of the two species 
[118]. Second, transport can stress bacteria making them 
viable but‑not culturable on selective agar plates, thus 
making plate count methods inefficient.
Molecular biology methods, that use nucleic acids as 
target for the tests allow detection of the viable but‑not 
culturable microorganisms, reduce the time required to 
obtain results and improve specificity. Various kinds of 
specific and sensitive PCR‑based tests have been devel‑
oped that are usually run in laboratories. Thus, they 
require the transportation of the samples from the site of 
analysis to the equipped facilities. Regarding the sensitiv‑
ity of Campylobacter to a variety of environmental condi‑
tions, the transport should be fast to reduce the loss of 
viability.
A portable device could help farmers to obtain a rapid 
detection of the pathogen, reducing the spread of the 
microorganism in the livestock and consequently of the 
food that could cause human illness. Barletta et al. [119] 
proposed a test based on melting‑point curve analysis 
which identifies post‑PCR products of C. jejuni. They 
standardized a classical PCR test with primers already 
reported against 16S rRNA of the Campylobacter spp. 
The test can be run using a multiple PCR for perform‑
ing detection of Salmonella, Shigella and Campylo-
bacter spp. Although selective, the method requires 
agarose gel migration of samples, making it slow and 
not adapted for screening high number of samples. 
In contrast, fluorescence‑based RT‑PCR methods are 
more robust and faster because no post‑PCR protocols 
are required. Unfortunately, both protocols require the 
extraction of DNA and, thus, depend on the efficiency 
of the enzymatic reaction. As results may depend on 
the reagents used for enzymatic reaction, PCR‑meth‑
ods avoiding the amplification step would be more 
accurate.
In last 10  years various kind of sensors have been 
developed to improve the rapidity, specificity and sim‑
plicity of Campylobacter detection. For this, proteins, 
nucleic acids, aptamers, antibodies and whole cells have 
been used as bioreceptors for the development of spe‑
cific point‑of‑care devices. Among them DNA‑biosen‑
sors seem to be the most attractive diagnostic tool for 
their rapidity, specificity and cost effectiveness. Indeed, 
DNA‑biosensors allow rapid, real‑time monitoring of 
hybridization with the target nucleic acids. Specificity 
of the system relies on oligonucleotide probes cova‑
lently immobilized on the sensing surface. Techniques, 
such as optical [120], acoustic [121], electrochemical 
[122], microwire [123] and localized surface plasmon 
resonance [124], have been proposed for traducing the 
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hybridization with the specific target nucleic acid to the 
pathogen detection. For instance, an organic light emit‑
ting diode (OLED) biosensor can be employed for the 
detection of Campylobacter in poultry meat samples, 
using a DNA probe attached to a glass slide (Figure 9). 
The labelling of the secondary DNA probe with an 
Alexa Fluor fluorophore allowed reaching a sensitivity 
of 0.37 ng/μL DNA and 1.5 × 101 CFU/g of Campylo-
bacter [125]. The method was demonstrated to be high 
sensitive even when no preliminary nucleic acid enrich‑
ment was performed. In addition, it is robustness, as 
zero false positive or false negative response have been 
obtained.
Zhang et al. [126] described the utilization of magneto 
strictive particle coated with three layers of silica to bind 
anti‑C. jejuni antibodies. Such functionalized magnetic 
particles were shown to detect C. jejuni in water released 
from chicken factories. Although bacterial cells are typi‑
cally diluted in water, the easy manipulation of magnetic 
particles allowed bacterial cells concentration giving a 
sensitive detection with the detection limit of 102 CFU/
mL. In another study, Wei et  al. [127] proposed a bio‑
sensor based on surface plasmon resonance for identi‑
fication of C. jejuni. Using specific antibodies against C. 
jejuni a sensitivity of 103 CFU/mL was reached.
Gnanaprakasa et  al. [128] developed an optical bio‑
sensor for the detection of C. jejuni based on diffraction 
optic technology and surface plasmon resonance. The 
hippuricase gene (hipO) of C. jejuni was used as a tar‑
get sequence. After being thiolated the complementary 
probe was immobilized on the gold surface of the sens‑
orchip. On‑chip hybridization was traduced to an optical 
signal which allowed C. jejuni quantification in infected 
samples with a detection limit of 5.0 nM.
Wald et al. [129] used a lateral flow method to detect 
C. jejuni or C. coli reaching a sensitivity of about 7.3 
log of CFU/g. Though not highly sensitive this device 
is portable and can be adapted to multiplex detection. 
Possibility to have multi‑pathogen in field diagnosis will 
significantly reduce time of detection allowing the acti‑
vation of control measures in a short time. The improv‑
ing of the hygiene of poultry will reduce the number of 
infections caused by Campylobacter in farms and thus 
the costs of human hospitalization.
11  Detection of Salmonella
Salmonella is a Gram‑negative, rod‑shaped, faculta‑
tive anaerobic, non‑spore‑forming, motile enterobacte‑
ria, that can grow over the temperature range from 7 
to 48  °C, and at optimum pH from 6.5 to 7.5. Salmo-
nella is a cause of foodborne illness worldwide and is 
responsible of livestock infections that can be transmit‑
ted from animals to humans. Poultry are considered 
as one of the most important Salmonella reservoirs. 
Various serotypes of Salmonella overlap between farm 
animals and humans [130]. Animals are mainly infected 
through feed, drinking water or environmental sources. 
Poultry farmers which suffers flock losses due to Salmo-
nella infection, suffers also for eggs and other consum‑
able poultry products losses. Various different strains 
of Salmonella have been identified although only two 
species have been recognized: S. enterica and S. bon-
gori. Salmonella enterica can be subdivided in subspe‑
cies, Salmonella enterica subsp. enterica (I), Salmonella 
enterica subsp. salamae (II), Salmonella enterica subsp. 
arizonae (IIIa), Salmonella enterica subsp. diarizonae 
(IIIb), Salmonella enterica subsp. houtenae (IV), Sal-
monella enterica subsp. houtenae (VI). Salmonella bon-
gori was originally designated as S. enterica subspecies 
V. The most important subspecies involved in poultry 
infections are Salmonella Typhimurium, Salmonella 
Enteritidis, Salmonella Virchow, Salmonella Hadar. 
Among all strains, S. Enteritidis is the serovar mostly 
implicated in salmonellosis worldwide. Affected birds 
are anorectic, weak, have diarrhea and may die shortly 
after hatching. Those who survive rest small in size and 
frequently carry localized infection of the ovary. In 
consequence survived hens may transmit the infection 
to the eggs and produce infected chicks.
The ISO 6579:2002 (AnnexD) method is currently 
the EU standard method for diagnosis of Salmonella in 
poultry samples. Other standard culture‑based meth‑
ods are available. Some of them have been validated by 
other regulatory agencies. Most of these conventional 
culture‑based methods comprise the following steps: (i) 
liquid pre‑enrichment on non‑selective medium followed 
by that on (ii) liquid selective media containing inhibit‑
ing compounds towards non‑Salmonella bacteria, (iii) 
culture on solid selective agar, and (iv) isolation of sus‑
pected colonies from the solid media, their incubation in 
a specific solid media followed by additional biochemical 
Figure 9 Visualization and detection of Campylobacter. A 
Transmission electron microscopy of Campylobacter cell. Bar, 2 µm. 
B OLED biosensor probing of a negative control sample containing 
a non‑Campylobacter DNA at 12.5 ng/µL, using a probe at 50 ng/µL. 
The spot was obtained upon deposition of 1 µL of the sample on the 
sensor surface. C OLED biosensor detection of Campylobacter DNA 
sequence at 12.5 ng/µL, using 50 ng/µL of the probe. The spot was 
obtained with 1 µL of the sample as previously explained [125].
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and serological tests for strain identification. All culture‑
based methods need complex laboratory equipment and 
at least 1 week to give results. Moreover, some serotypes 
cannot be detected on the selective media used for iso‑
lation, thus, false negatives can be provided by the test. 
For instance, Salmonella Virchow cannot be cultivated 
on agar.
In consequence, immunological and serological tests 
have been developed for Salmonella diagnosis. The iden‑
tification step that uses biochemical assays detecting a 
specific biomarker has reduced the volume of the rea‑
gents allowing the simultaneous inoculum of many wells 
on the same strip leading to a reaction that can give the 
answer within 24 h. Many of such kits are commercially 
available (as API 20E, bioMerieux; Enterotube II, BD 
diagnostics, etc.). Nevertheless, it is difficult to incorpo‑
rate immunoassays into an array to detect multiple tar‑
gets due to the high cross‑reactivity between antibodies. 
On the other side, ELISA, although high sensitive and 
fast, still can give false negative results, cross‑reactivity 
problems, and need a pre‑enrichment step [131].
The utilization of molecular biology and PCR‑based 
methods, such RT‑PCR and Digital‑PCR, can reduce the 
time for Salmonella detection to several hours. These 
methods may be employed even when serotyping fails 
due to the change or loss of the surface antigens. Vari‑
ous kinds of rapid tests for Salmonella have been devel‑
oped and approved, including the VIDAS Salmonella 
(SLM) method, the immuno‑concentration Salmonella 
(ICS) method, the Tecra Unique Salmonella test, and 
the polymerase chain reaction PCR based BAX™ sys‑
tem, approved by the Association of Official Analytical 
Chemists (AOAC) International. The results are obtained 
within 24  h. Also Dynal BeadRetriever, Pathatrix, and 
BioVeris M1M Platform based on immunomagnetic 
separation (IMS) systems, and many others are currently 
used. Gene‑Trak® (Neogen Corporation) bases on DNA 
probe hybridization [132] allows after the lysis of the 
target cells, the release of DNA for hybridization to the 
probe. Most molecular tests use an enrichment step to 
increase the sensitivity extending the time of the test and 
require supplementary equipment for the analysis.
In addition to food‑borne pathogens detection and 
sanitary control of farms, the possible utilization of Sal-
monella for bioterrorism led to the development of port‑
able biosensor‑based detection methods. Biosensors may 
detect specific Salmonella proteins or DNA sequences 
in a rapid, specific, simple and sensitive way. Chai et al. 
[133] described a wireless magneto elastic mass‑sensitive 
biosensor for the detection of S. Typhimurium, able to 
detect 1.6 × 102 CFU/mL. Wang et al. [133] reported the 
utilization of microcantilever decorated with peptides 
having high affinities to various strains of Salmonella 
able to detect only one cell of the pathogen in an infected 
sample. The cantilever bends lightly, due to the capture 
of a bacterium by the specific peptide, and a laser acti‑
vates the alarm. The authors used phage‑derived peptides 
to obtain an array for parallel detecting of eight serovars. 
Phage display uses genetic modification of viruses that 
infect bacteria, bacteriophages, to insert a sequence of 
the peptide that specifically recognizes one biomarker 
into a phage coat protein gene. In that way, the phage 
starts to express the peptide on its surface. The display‑
ing phages can be attached on the biosensor surface and 
assure specific Salmonella detection.
A lateral flow system for Salmonella AD, produced by 
the DuPont, uses two‑step enrichment (16–22  h plus 
6–8  h) before the sample insertion on the strip. Strips 
contained colloidal gold conjugated anti‑Salmonella 
antibodies coated onto the sample pad. The test provides 
results in 10 min. Strips have been validated for Salmo-
nella detection on raw meat, chicken sera, eggs, pro‑
cessed meat, fruits, vegetables, etc. This method was also 
confirmed on meat samples spiked with 1–4  CFU/25  g 
before the enrichment.
Bulut [134] reported the development of a lateral flow 
immunochromatographic test platform for Salmonella 
using the invA gene as a target. This gene encodes the 
protein responsible for the invasivity of the pathogen. The 
platform requires no labeling of the target as it detects 
amplicons obtained by using specific primers followed by 
sandwich hybridization. Nevertheless, the method is not 
quantitative since it involves a PCR step. Fang et al. [135] 
developed a lateral flow biosensor based on aptamers to 
detect Salmonella. This method needed an amplification 
step to produce an amplified ssDNA before its deposition 
onto the sensor membrane. The reported sensitivity was 
101 CFU/mL.
Microfluidic devices have also been used for the 
detection of Salmonella. Kim et  al. [136] detected S. 
Typhimurium using a microfluidic device and specific 
anti‑Salmonella antibodies able to efficiently capture 
Salmonella cells. S. Typhimurium was used to spike sam‑
ples at various concentrations and establish the detection 
limit. A portable fluorometer using a LED unit detected 
the signal produced by the quantum dots conjugated to 
antibodies. The detection limit obtained for the sensor 
was 103 CFU/mL Salmonella in chicken meat extract.
12  Detection of bovine respiratory syncytial 
viruses
Bovine respiratory syncytial virus (BRSV) is spread 
worldwide and represents a major contributor of respira‑
tory disease in cattle, especially in young beef and dairy 
cattle. The high prevalence of seropositive cattle infec‑
tion is common in the cattle population making BRSV 
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the most economically important and outstanding wel‑
fare issues for industrialized beef cattle producers and 
animal health organizations. The virus seems to spread 
by an aerosol route and can be easily transmitted by 
contact with respiratory secretions from infected cattle. 
Frequently, BRSV infection is associated with secondary 
bacterial infections that are treated by the massive use of 
antibiotics. In consequence, BRSV represents an addi‑
tional public health‑concern through the risk of antibi‑
otic‑resistance developing.
BRSV is a single‑strained, negative‑sense RNA envel‑
oped virus classified as a Pneumovirus of Paramyxoviri-
dae family. The genome of BRSV encodes for 11 proteins: 
nucleocapsid (N), phosphoprotein, large polymerase, 
transcriptional antitermination factor M2‑1 and RNA 
regulatory protein M2‑2 that all associate the genomic 
RNA, then attachment (G), fusion (F) and small hydro‑
phobic protein that are transmembrane surface glyco‑
proteins, while matrix or membrane protein (M) is a 
nonglycosylated and associates with the inner face of the 
envelope. In addition, two nonstructural proteins, named 
NS1 and NS2, accumulate within the infected cells.
After the incubation period estimated to take between 
2 and 5  days, BRSV infection is usually limited to the 
upper respiratory tract giving clinical signs that may 
range from minimal to severe with dyspnea and death. 
Affected calves can have tachypnea, ocular serous secre‑
tions, dry muzzle, reduced activity, anorexia, and high 
fevers. The clinical signs may last until 7–10  days post‑
infection. Interestingly, the antibody response is fre‑
quently developed few days before clinical signs appear. 
Thus, testing serum samples pooled from a number of 
animals in a respiratory outbreak may help diagnosis. 
Still, although clinical signs may suggest BRSV infection, 
diagnosis of BRSV requires a laboratory confirmation.
PCR is commonly used as a molecular method for 
BRSV diagnosis. However, the virus isolation is difficult, 
except in some cases upon the acute phases of infection. 
Detection of negative‑sense RNA genome or mRNA of 
the virus is even more delicate than detection of viral 
proteins. First, RNAs are sensitive to RNAse digestion 
and degradation and have shorter life time than proteins. 
Second, RSV mRNA is expressed cyclically, while protein 
expression is stable and increases in a regular manner 
over time. In consequence, ELISA test that quantify the 
RSV fusion protein subunits F0 and F1, expressed by all 
RSV strains, provides an efficient diagnostic tool. Simi‑
larly, the detection of specific antibodies in serum sam‑
ples has proved useful to establish a diagnosis of BRSV 
antigen in the acute sample. Interestingly, the antibody 
titer in animals with developed clinical signs of the dis‑
ease is usually higher than in the sample taken several 
weeks later.
Cai et  al. [137] proposed a label‑free electrochemi‑
cal biosensor based on molecular beacon for detection 
of target mRNA from RSV. Molecular beacons are oli‑
gonucleotide hybridization probes in a form of a hair‑
pin shaped molecules. Within the hairpin structure a 
streptavidin binding aptamer sequence was blocked for 
this assay. Upon hybridization of the beacon with specific 
nucleic acid sequence, the hairpin opens to allow bind‑
ing to streptavidin‑HRP protein complex. In that way, 
the hybridization event can be quantified by the enzy‑
matic reaction using a HRP substrate, tetramethylben‑
zidine (TMB). The sensor was shown to detect 13 amol 
of RSV mRNA in a 4 µL total volume of a complex bio‑
logical media. The high specificity and selectivity of the 
device was demonstrated as sensor detected specific RSV 
mRNA but not one base mismatched sequence.
In another study, the HRP‑TMB reaction was used for 
electrochemical detection of RSV specific antigens [138]. 
For this, the polystyrene array slide that allows antibody 
immobilization was attached with disposable screen‑
printed electrodes. The RSV fusion protein was captured 
in a sandwich by a specific monoclonal antibody attached 
to the polystyrene surface and a second antibody‑coupled 
with HRP. The enzymatic reaction HRP‑TMB was tra‑
duced into an amperometric signal by the electrode. The 
whole test needed only 25 min to produce result show‑
ing similar selectivity and sensibility to commercial RT‑
PCR or immunofluorescent tests when probed on clinical 
samples.
Perez et  al. [139] described the detection of RSV by 
nanoparticle amplification of immuno‑PCR assay. Their 
test detects RSV by viral particles capturing into a sand‑
wich formed between two different antibodies specific 
against the F protein. The first antibody was attached to 
magnetic beads to allow extraction, while the second was 
co‑immobilized onto gold nanoparticles with specific 
DNA sequences. After extraction the hybridized DNA 
can be released by heating and detected via RT‑PCR. It 
was shown that this nanoparticle amplified immune‑
PCR assay not only provided better virus sampling but 
also reduce the effect of PCR‑induced variation in sam‑
ple replicates by increasing the tag DNA concentration 
and by lowering the background signaling. Compared to 
ELISA and RT‑PCR detection, the nanoparticle amplified 
immune‑PCR showed a several 1000‑fold improvement 
in the limit of detection as it detected 4.1 PFU/mL.
13  Conclusions
We show some advanced biotechnological approaches 
that allow early detection of pathogens that affect 
domestic livestock and poultry. The pathogens pre‑
sented in this review entail significant economic losses 
due to weaken food production systems, increased 
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veterinary costs and may pose a direct threat to global 
food security. In addition, infection diseases of animal 
population carry public health risks of outbreaks as well 
as sporadic and endemic zoonoses. Conventional diag‑
nostic techniques are frequently time consuming, labor 
intensive and require to be performed on sophisticated 
equipment by trained professionals with certain experi‑
ence. New technologies are employed to overcome these 
difficulties and to provide accurate, simple and afford‑
able biosensor devices that can give rapid response to 
test. Biosensors have been designed to detect the tar‑
get (protein or nucleic acid sequence) related to the 
pathogen by using sensitive and selective recognition 
properties of antibodies, aptamers, glucans and DNA 
probes. These sensing elements are associated with a 
transducing element (electrochemical, optical or colori‑
metric) that emits a direct signal when the target is rec‑
ognized. Although most of presented analytical devices 
are used only in research laboratories, it is expected 
that more biosensors will emerge in the future given 
the rapid spread of livestock infectious diseases. There 
is a strong need to develop portable, miniaturized and 
multitargeting devices that can be used directly in the 
field by veterinaries or by competent national authori‑
ties responsible for organizing disease controls. To be 
recommended by the World Animal Health Organiza‑
tion, biosensors for animal infectious disease diagnosis 
have to undergo inter‑laboratories testing to be har‑
monized and validated. To be used outside research 
laboratories, a biosensor usually needs adaptation for 
implementation in field conditions in order to reduce 
the risk of obtaining false positive or negative results. 
Among presented detection strategies, the nucleic acid‑
based biosensors appear being highly suitable for swift 
and sensitive testing. Their limitation lays in sample 
preparation steps that include nucleic acids extraction 
and amplification. The analytical properties of anti‑
body‑ and aptamer‑based biosensors depend strongly 
on selectivity of these biomolecules and also on the sta‑
bility obtained after their immobilization on the sensor 
surface. Furthermore, over the long term, we believe 
that biosensors technology combining nanotechnolo‑
gies, advances nucleic acid amplification methods, and 
next‑generation sequencing analysis will be a powerful 
systemic tool for pathogens detection and surveillance 
system to control animal disease outbreaks and preven‑
tion. Development of reference materials, harmoniza‑
tion of sampling methods, mobile analysis and data 
networking will significantly support developing of high 
sensitive and selective biosensors for real‑time in field 
monitoring (Figure  10). Surveillance big data obtained 
from those diagnostic technologies will help disease 
prevention and pathogens control to livestock and poul‑
try industrials and will improve animal welfare.
Figure 10 Elements of integrated portable diagnostic laboratory. Advanced analytical technologies will offer to veterinary practitioners a 
suitcase containing consumables, reagents and devices to perform in field diagnostics with laboratory‑grade performance.
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